Ridgetech Inc. — Director's Dealing 2022

May 3, 2022

6-K 1 ea159304-6k_chinajojo.htm CURRENT REPORT OF FOREIGN PRIVATE ISSUER

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2022

Commission File Number: 001-40724

CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English)

Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District,

Hangzhou City, Zhejiang Province, People’s Republic of China, 310008 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

China Jo-Jo Drugstores, Inc., a Cayman Islands company (the “Company”) furnishes under the cover of Form 6-K the following:

Grant of Restricted Stock under the Company’s Equity Incentive Plan

On April 28, 2022, the compensation committee of our board of directors granted a total of 850,000 restricted stock awards to seven individuals, including three directors and/or executive officers, as follows: (i) 340,000 restricted stock awards to Lei Liu, Chief Executive Officer and Director; (ii) 50,000 restricted stock awards to Ming Zhao, Chief Financial Officer; and (iii) 260,000 restricted stock awards to Li Qi, Director. The remaining 200,000 restricted stock awards were granted to non-executive management employees. All the restricted stock awards were granted under our Amended and Restated 2010 Equity Incentive Plan, as amended. The restricted stock awards vest six months from the grant date.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 3, 2022
By:	/s/ Lei Liu
Name:	Lei Liu
Title:	Chief Executive Officer

Field: Page; Sequence: 3; Options: Last

Field: /Page